Table 3.
Autoimmune Dry Eye (AIDE) | Meibomian Gland Dysfunction (MGD) | ||||
---|---|---|---|---|---|
All Patients in the Study | Painless | Painful | Painless | Painful | |
Oxford score |
|
†††† |
‡‡ |
|
●● |
BUT (s, mean ± SD) | 4.94 ± 0.18 | 4.82 ± 0.35 | 4.19 ± 0.31 | 5.70 ± 0.36 | 5.00 ± 0.39 ‡ |
NIKBUT (first, mean ± SD) | 5.06 ± 5.35 | 4.08 ± 4.77 | 3.55 ± 3.65 | 5.83 ± 5.14 | 6.66 ± 7.45 |
NIKBUT (average, mean ± SD) | 7.78 ± 6.90 | 6.8 ± 6.52 | 5.10 ± 5.41 | 9.24 ± 6.87 | 9.27 ± 8.18 ‡ |
Schirmer (mm/5 min, mean ± SD) | 10.9 ± 10.0 | 10.1 ± 10.1 | 8.8 ± 9.1 | 12.8 ± 10.6 | 12.0 ± 9.8 |
Tear meniscus (mm, mean ± SD) | 0.209 ± 0.188 | 0.172 ± 0.198 | 0.224 ± 0.193 | 0.235 ± 0.200 | 0.196 ± 0.141 |
Osmolarity (mOsmol/L, mean ± SD) | 309 ± 17 | 307 ± 15 | 311 ± 19 | 306 ± 16 | 310 ± 19 |
● significant difference between painless MGD vs. painful MGD; † significant difference between painless AIDE vs. painless MGD; ‡ significant difference between painful AIDE vs. painful MGD. Statistical significance is illustrated based on number of signs as follows: one sign = p < 0.05, two signs = p < 0.01, four signs = p < 0.0001.